Diana Escolar

Chief Medical Officer at Akashi Therapeutics

Dr. Escolar has applied nearly two decades of research in adult and pediatric neuromuscular diseases to help guide the development of new therapies. She has provided medical oversight and guidance for all phases of the drug discovery process as well as target identification, IND submission and clinical trial operations for various drug development firms. She is currently a member of the medical staff at the Kennedy Krieger Institute, Genetic Muscle Disorders department, and an associate professor of neurology at Johns Hopkins School of Medicine. Dr. Escolar was the co-founder and director of the Cooperative International Neuromuscular Research Group, an international consortium of academic medical centers developing and conducting target identification, translational studies and clinical studies in Duchenne Muscular Dystrophy and related disorders. She received her M.D. from the University of Buenos Aires, School of Medicine in Argentina and her post-graduate training from Boston University- and Harvard Medical School affiliated-programs.

Peers

View in org chart

Timeline

  • Chief Medical Officer

    Current role